Lean Mass Preservation: GLP-1 treatment is effective in promoting weight loss
Combination Therapy: While low-risk on their own, GLP-1 RAs increase hypoglycemia risk when combined with insulin or sulfonylureas
While the IOM had based B12 needs on the amount required to correct hematological parameters for people with pernicious anemia, the EFSA had almost 20 more years of research to draw on, and concluded that the most suitable approach was basing needs on biomarkers (serum B12, holotranscobalamin, MMA, and homocysteine)
[2] The risk of gallstones may be decreased by maintaining a healthy weight with exercise and a healthy diet
Minimal hepatic encephalopathy and critical flicker frequency are associated with survival of patients with cirrhosis
Regarding FDA approval: because this is a compounded product, it is not directly FDA-approved